NEW YORK--(BUSINESS WIRE)--Warby Parker Inc. (NYSE: WRBY) (“Warby Parker” or the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the third quarter ended September 30, 2024.
“Warby Parker’s Q3 performance is a direct result of our team’s commitment to making progress on our strategic initiatives, in particular expanding our marketing efforts, investing in store expansion, and enhancing our holistic vision care offering,” shared Co-Founder and Co-CEO Neil Blumenthal.
“We’re particularly encouraged by the momentum we’re seeing in early Q4. As we close out the year, we’re focused on continuing to capture market share, bring new customers to the brand, and deliver on our commitment to accelerate growth and improve profitability year over year,” said Co-Founder and Co-CEO Dave Gilboa.
Third Quarter 2024 Highlights
- Net revenue increased $22.6 million, or 13.3%, to $192.4 million, as compared to the prior year period.
- Active Customers increased 5.6% to 2.43 million on a trailing 12-month basis, and Average Revenue per Customer increased 7.5% to $305.
- GAAP net loss of $4.1 million.
- Adjusted EBITDA Margin(1) increased 2.5 points to 9.0%.
- Net cash provided by operating activities of $27.3 million.
- Free Cash Flow(1) of $13.1 million.
- Opened 13 net new stores during the quarter, ending Q3 with 269 stores.
Third Quarter 2024 Year Over Year Financial Results
- Net revenue increased $22.6 million, or 13.3%, to $192.4 million.
- Active Customers increased 5.6% to 2.43 million on a trailing 12-month basis, and Average Revenue per Customer increased 7.5% to $305.
- Gross margin was 54.5% compared to 54.6% in the prior year. The decrease in gross margin was primarily driven by the sales growth of contact lenses and increased doctor headcount, partially offset by efficiencies in our owned optical laboratories and lower outbound customer shipping costs as a percent of revenue, which were both driven by higher glasses growth.
- Selling, general, and administrative expenses (“SG&A”) were $111.5 million, down $1.0 million from the prior year, and represented 57.9% of revenue, down from 66.2% in the prior year. The primary drivers of decreased SG&A were reduced stock-based compensation costs and lower corporate expenses, partially offset by higher payroll-related costs from growth in our retail team associated with store expansion, and investments in marketing. Adjusted SG&A(1) was $100.6 million, or 52.3% of revenue, compared to $93.4 million, or 55.0% of revenue in the prior year.
- GAAP net loss improved $13.3 million to $4.1 million, primarily as a result of leveraging our expense base on higher revenue.
- Adjusted EBITDA(1) increased $6.3 million to $17.3 million, and Adjusted EBITDA Margin(1) increased 2.5 points to 9.0%.
Balance Sheet Highlights
Warby Parker ended the third quarter of 2024 with $251.0 million in cash and cash equivalents.
2024 Outlook
For the full year 2024, Warby Parker is raising its guidance as follows:
- Net revenue of $765 to $768 million, representing growth of approximately 14% to 15% versus full year 2023.
- Adjusted EBITDA(1) of approximately $73 million at the midpoint of our revenue range, based on an Adjusted EBITDA Margin(1) of 9.5%.
- On track to open 40 new stores this year.
“We’re pleased that we delivered continued revenue growth and adjusted EBITDA margin expansion in the third quarter. Given outperformance year-to-date, we are raising our full year revenue and adjusted EBITDA guidance, which we anticipate will set the stage for a strong 2025,” said Chief Financial Officer Steve Miller.
The guidance and forward-looking statements made in this press release and on our conference call are based on management's expectations as of the date of this press release.
(1) Please see the reconciliation of non-GAAP financial measures to the most comparable GAAP financial measure in the section titled “Non-GAAP Financial Measures” below.
Webcast and Conference Call
A conference call to discuss Warby Parker’s third quarter 2024 results, as well as fourth quarter and full year 2024 outlook, is scheduled for 8:00 a.m. ET on November 7, 2024. To participate, please dial 833-470-1428 from the U.S. or 404-975-4839 from international locations. The conference passcode is 681992. A live webcast of the conference call will be available on the investors section of the Company’s website at investors.warbyparker.com where presentation materials will also be posted prior to the conference call. A replay will be made available online approximately two hours following the live call for a period of 90 days.
Forward-Looking Statements
This press release and the related conference call, webcast and presentation contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may relate to, but are not limited to, expectations of future operating results or financial performance, including expectations regarding achieving profitability and growth in our e-commerce channel, delivering stakeholder value, growing market share, and our guidance for the quarter and year ending December 31, 2024; expectations regarding the number of new store openings during the year ending December 31, 2024; management’s plans, priorities, initiatives and strategies; and expectations regarding growth of our business. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “toward,” “will,” or “would,” or the negative of these words or other similar terms or expressions. You should not put undue reliance on any forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved, if at all.
Forward-looking statements are based on information available at the time those statements are made and are based on current expectations, estimates, forecasts, and projections as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond our control, that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in this press release may not occur and actual results could differ materially from those anticipated or implied in the forward-looking statements. These risks and uncertainties include our ability to manage our future growth effectively; our expectations regarding cost of goods sold, gross margin, channel mix, customer mix, and selling, general, and administrative expenses; increases in component and shipping costs and changes in supply chain; our reliance on our information technology systems and enterprise resource planning systems for our business to effectively operate and safeguard confidential information; our ability to invest in and incorporate new technologies into our products and services; our ability to engage our existing customers and obtain new customers; our ability to expand in-network access with insurance providers; planned new retail stores in 2024 and going forward; an overall decline in the health of the economy and other factors impacting consumer spending, such as recessionary conditions, inflation, government instability, and geopolitical unrest; our ability to compete successfully; our ability to manage our inventory balances and shrinkage; the growth of our brand awareness; our ability to recruit and retain optometrists, opticians, and other vision care professionals; the spread of new infectious diseases; the effects of seasonal trends on our results of operations; our ability to stay in compliance with extensive laws and regulations that apply to our business and operations; our ability to adequately maintain and protect our intellectual property and proprietary rights; our reliance on third parties for our products, operation and infrastructure; our duties related to being a public benefit corporation; the ability of our Co-Founders and Co-CEOs to exercise significant influence over all matters submitted to stockholders for approval; the effect of our multi-class structure on the trading price of our Class A common stock; and the increased expenses associated with being a public company. Additional information regarding these and other risks and uncertainties that could cause actual results to differ materially from the Company's expectations is included in our most recent reports filed with the SEC on Form 10-K and Form 10-Q. Except as required by law, we do not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.
Additional information regarding these and other factors that could affect the Company’s results is included in the Company’s SEC filings, which may be obtained by visiting the SEC's website at www.sec.gov. Information contained on, or that is referenced or can be accessed through, our website does not constitute part of this document and inclusions of any website addresses herein are inactive textual references only.
Glossary
Active Customers is defined as unique customer accounts that have made at least one purchase in the preceding 12-month period.
Average Revenue per Customer is defined as the sum of the total net revenues in the preceding 12-month period divided by the current period Active Customers.
Non-GAAP Financial Measures
We use Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Cost of Goods Sold (“Adjusted COGS”), Adjusted Gross Margin, Adjusted Gross Profit, Adjusted Selling, General, and Administrative Expenses (“Adjusted SG&A”), and Free Cash Flow as important indicators of our operating performance. Collectively, we refer to these non-GAAP financial measures as our “Non-GAAP Measures.” The Non-GAAP Measures, when taken collectively with our GAAP results, may be helpful to investors because they provide consistency and comparability with past financial performance and assist in comparisons with other companies, some of which use similar non-GAAP financial information to supplement their GAAP results.
Adjusted EBITDA is defined as net income (loss) before interest and other income, taxes, and depreciation and amortization as further adjusted for asset impairment costs, stock-based compensation expense and related employer payroll taxes, amortization of cloud-based software implementation costs, non-cash charitable donations, charges for certain legal matters outside the ordinary course of business, and non-recurring costs such as restructuring costs, major system implementation costs, and transaction costs. Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by net revenue.
Adjusted COGS is defined as cost of goods sold adjusted for stock-based compensation expense and related employer payroll taxes.
Adjusted Gross Profit is defined as net revenue minus Adjusted COGS. Adjusted Gross Margin is defined as Adjusted Gross Profit divided by net revenue.
Adjusted SG&A is defined as SG&A adjusted for stock-based compensation expense and related employer payroll taxes, non-cash charitable donations, charges for certain legal matters outside the ordinary course of business, and non-recurring costs such as restructuring costs, major system implementation costs, and transaction costs.
Free Cash Flow is defined as net cash provided by operating activities minus purchases of property and equipment.
The Non-GAAP Measures are presented for supplemental informational purposes only. A reconciliation of historical GAAP to Non-GAAP financial information is included under “Selected Financial Information” below.
We have not reconciled our Adjusted EBITDA Margin guidance to GAAP net income (loss) margin, or net margin, or Adjusted EBITDA guidance to GAAP net income (loss) because we do not provide guidance for GAAP net margin or GAAP net income (loss) due to the uncertainty and potential variability of stock-based compensation and taxes, which are reconciling items between GAAP net margin and Adjusted EBITDA Margin and GAAP net income (loss) and Adjusted EBITDA, respectively. Because such items cannot be reasonably provided without unreasonable efforts, we are unable to provide a reconciliation of the Adjusted EBITDA Margin guidance to GAAP net margin and Adjusted EBITDA guidance to GAAP net income (loss). However, such items could have a significant impact on GAAP net margin and GAAP net income (loss).
About Warby Parker
Warby Parker (NYSE: WRBY) was founded in 2010 with a mission to inspire and impact the world with vision, purpose, and style–without charging a premium for it. Headquartered in New York City, the co-founder-led lifestyle brand pioneers ideas, designs products, and develops technologies that help people see, from designer-quality prescription glasses (starting at $95) and contacts, to eye exams and vision tests available online and in our 269 retail stores across the U.S. and Canada.
Warby Parker aims to demonstrate that businesses can scale, do well, and do good in the world. Ultimately, the Company believes in vision for all, which is why for every pair of glasses or sunglasses sold, it distributes a pair to someone in need through its Buy a Pair, Give a Pair program. To date, Warby Parker has worked alongside its nonprofit partners to distribute more than 15 million glasses to people in need.
Selected Financial Information
Warby Parker Inc. and Subsidiaries
|
|||||||
|
September 30,
|
|
December 31,
|
||||
Assets |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
251,032 |
|
|
$ |
216,894 |
|
Accounts receivable, net |
|
1,094 |
|
|
|
1,779 |
|
Inventory |
|
52,766 |
|
|
|
62,234 |
|
Prepaid expenses and other current assets |
|
16,317 |
|
|
|
17,712 |
|
Total current assets |
|
321,209 |
|
|
|
298,619 |
|
|
|
|
|
||||
Property and equipment, net |
|
166,500 |
|
|
|
152,332 |
|
Right-of-use lease assets |
|
141,552 |
|
|
|
122,305 |
|
Other assets |
|
8,729 |
|
|
|
7,056 |
|
Total assets |
$ |
637,990 |
|
|
$ |
580,312 |
|
|
|
|
|
||||
Liabilities and Stockholders’ Equity |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Accounts payable |
$ |
36,663 |
|
|
$ |
22,456 |
|
Accrued expenses |
|
46,015 |
|
|
|
46,320 |
|
Deferred revenue |
|
19,216 |
|
|
|
31,617 |
|
Current lease liabilities |
|
26,068 |
|
|
|
24,286 |
|
Other current liabilities |
|
2,155 |
|
|
|
2,411 |
|
Total current liabilities |
|
130,117 |
|
|
|
127,090 |
|
|
|
|
|
||||
Non-current lease liabilities |
|
170,104 |
|
|
|
150,171 |
|
Other liabilities |
|
1,019 |
|
|
|
1,264 |
|
Total liabilities |
|
301,240 |
|
|
|
278,525 |
|
Commitments and contingencies |
|
|
|
||||
Stockholders’ equity: |
|
|
|
||||
Common stock, $0.0001 par value; Class A: 750,000,000 shares authorized at September 30, 2024 and December 31, 2023, 101,590,781 and 98,368,239 issued and outstanding at September 30, 2024 and December 31, 2023, respectively; Class B: 150,000,000 shares authorized at September 30, 2024 and December 31, 2023, 18,674,743 and 19,788,682 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively, convertible to Class A on a one-to-one basis |
|
12 |
|
|
|
12 |
|
Additional paid-in capital |
|
1,018,751 |
|
|
|
970,135 |
|
Accumulated deficit |
|
(680,344 |
) |
|
|
(666,831 |
) |
Accumulated other comprehensive loss |
|
(1,669 |
) |
|
|
(1,529 |
) |
Total stockholders’ equity |
|
336,750 |
|
|
|
301,787 |
|
Total liabilities and stockholders’ equity |
$ |
637,990 |
|
|
$ |
580,312 |
|
Warby Parker Inc. and Subsidiaries
|
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
Net revenue |
$ |
192,447 |
|
|
$ |
169,849 |
|
|
$ |
580,672 |
|
|
$ |
507,910 |
|
Cost of goods sold |
|
87,580 |
|
|
|
77,117 |
|
|
|
256,964 |
|
|
|
229,752 |
|
Gross profit |
|
104,867 |
|
|
|
92,732 |
|
|
|
323,708 |
|
|
|
278,158 |
|
|
|
|
|
|
|
|
|
||||||||
Selling, general, and administrative expenses |
|
111,480 |
|
|
|
112,499 |
|
|
|
344,404 |
|
|
|
328,585 |
|
Loss from operations |
|
(6,613 |
) |
|
|
(19,767 |
) |
|
|
(20,696 |
) |
|
|
(50,427 |
) |
|
|
|
|
|
|
|
|
||||||||
Interest and other income, net |
|
2,842 |
|
|
|
2,655 |
|
|
|
7,965 |
|
|
|
6,815 |
|
|
|
|
|
|
|
|
|
||||||||
Loss before income taxes |
|
(3,771 |
) |
|
|
(17,112 |
) |
|
|
(12,731 |
) |
|
|
(43,612 |
) |
Provision for income taxes |
|
301 |
|
|
|
301 |
|
|
|
782 |
|
|
|
538 |
|
Net loss |
$ |
(4,072 |
) |
|
$ |
(17,413 |
) |
|
$ |
(13,513 |
) |
|
$ |
(44,150 |
) |
|
|
|
|
|
|
|
|
||||||||
Net loss per share attributable to common stockholders, basic and diluted |
$ |
(0.03 |
) |
|
$ |
(0.15 |
) |
|
$ |
(0.11 |
) |
|
$ |
(0.38 |
) |
Weighted average shares used in computing net loss per share attributable to common stockholders, basic and diluted |
|
120,885,913 |
|
|
|
118,003,640 |
|
|
|
120,041,740 |
|
|
|
116,995,545 |
|
Warby Parker Inc. and Subsidiaries
|
|||||||
|
Nine Months Ended
|
||||||
|
|
2024 |
|
|
|
2023 |
|
Cash flows from operating activities |
|
|
|
||||
Net loss |
$ |
(13,513 |
) |
|
$ |
(44,150 |
) |
Adjustments to reconcile net loss to net cash provided by operating activities: |
|
|
|
||||
Depreciation and amortization |
|
33,533 |
|
|
|
28,184 |
|
Stock-based compensation |
|
38,664 |
|
|
|
54,083 |
|
Non-cash charitable contribution |
|
2,196 |
|
|
|
3,191 |
|
Asset impairment charges |
|
522 |
|
|
|
1,407 |
|
Amortization of cloud-based software implementation costs |
|
2,862 |
|
|
|
1,679 |
|
Change in operating assets and liabilities: |
|
|
|
||||
Accounts receivable, net |
|
686 |
|
|
|
714 |
|
Inventory |
|
9,468 |
|
|
|
5,231 |
|
Prepaid expenses and other assets |
|
(1,148 |
) |
|
|
410 |
|
Accounts payable |
|
13,267 |
|
|
|
2,756 |
|
Accrued expenses |
|
2,728 |
|
|
|
(1,207 |
) |
Deferred revenue |
|
(12,401 |
) |
|
|
(8,005 |
) |
Other current liabilities |
|
(256 |
) |
|
|
(116 |
) |
Right-of-use lease assets and current and non-current lease liabilities |
|
2,469 |
|
|
|
3,458 |
|
Other liabilities |
|
(245 |
) |
|
|
(309 |
) |
Net cash provided by operating activities |
|
78,832 |
|
|
|
47,326 |
|
Cash flows from investing activities |
|
|
|
||||
Purchases of property and equipment |
|
(46,311 |
) |
|
|
(40,098 |
) |
Investment in optical equipment company |
|
(2,000 |
) |
|
|
(1,000 |
) |
Net cash used in investing activities |
|
(48,311 |
) |
|
|
(41,098 |
) |
Cash flows from financing activities |
|
|
|
||||
Proceeds from stock option exercises |
|
2,686 |
|
|
|
1,017 |
|
Proceeds from shares issued in connection with employee stock purchase plan |
|
1,068 |
|
|
|
1,124 |
|
Net cash provided by financing activities |
|
3,754 |
|
|
|
2,141 |
|
Effect of exchange rates on cash |
|
(137 |
) |
|
|
(989 |
) |
Net change in cash and cash equivalents |
|
34,138 |
|
|
|
7,380 |
|
Cash and cash equivalents, beginning of period |
|
216,894 |
|
|
|
208,585 |
|
Cash and cash equivalents, end of period |
$ |
251,032 |
|
|
$ |
215,965 |
|
Supplemental disclosures |
|
|
|
||||
Cash paid for income taxes |
$ |
782 |
|
|
$ |
400 |
|
Cash paid for interest |
|
169 |
|
|
|
155 |
|
Cash paid for amounts included in the measurement of lease liabilities |
|
21,668 |
|
|
|
27,124 |
|
Non-cash investing and financing activities: |
|
|
|
||||
Purchases of property and equipment included in accounts payable and accrued expenses |
$ |
5,553 |
|
|
$ |
5,941 |
|
Warby Parker Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Measures (Unaudited)
The following table reconciles Adjusted EBITDA and Adjusted EBITDA Margin to the most directly comparable GAAP measure, which is net loss:
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
(unaudited, in thousands) |
|
(unaudited, in thousands) |
||||||||||||
Net loss |
$ |
(4,072 |
) |
|
$ |
(17,413 |
) |
|
$ |
(13,513 |
) |
|
$ |
(44,150 |
) |
Adjusted to exclude the following: |
|
|
|
|
|
|
|
||||||||
Interest and other income, net |
|
(2,842 |
) |
|
|
(2,655 |
) |
|
|
(7,965 |
) |
|
|
(6,815 |
) |
Provision for income taxes |
|
301 |
|
|
|
301 |
|
|
|
782 |
|
|
|
538 |
|
Depreciation and amortization expense |
|
11,829 |
|
|
|
9,760 |
|
|
|
33,533 |
|
|
|
28,184 |
|
Asset impairment charges |
|
101 |
|
|
|
757 |
|
|
|
522 |
|
|
|
1,407 |
|
Stock-based compensation expense(1) |
|
10,961 |
|
|
|
16,466 |
|
|
|
39,373 |
|
|
|
54,496 |
|
Non-cash charitable donation(2) |
|
— |
|
|
|
2,591 |
|
|
|
2,196 |
|
|
|
3,191 |
|
Amortization of cloud-based software implementation costs(3) |
|
854 |
|
|
|
853 |
|
|
|
2,862 |
|
|
|
1,679 |
|
ERP implementation costs(4) |
|
— |
|
|
|
371 |
|
|
|
— |
|
|
|
4,413 |
|
Other costs(5) |
|
176 |
|
|
|
— |
|
|
|
1,479 |
|
|
|
— |
|
Adjusted EBITDA |
$ |
17,308 |
|
|
$ |
11,031 |
|
|
$ |
59,269 |
|
|
$ |
42,943 |
|
Adjusted EBITDA Margin |
|
9.0 |
% |
|
|
6.5 |
% |
|
|
10.2 |
% |
|
|
8.5 |
% |
| (1) | Represents expenses related to the Company’s equity-based compensation programs and related employer payroll taxes, which may vary significantly from period to period depending upon various factors including the timing, number, and the valuation of awards granted, and vesting of awards including the satisfaction of performance conditions, as well as the issuance of 48,486 Class A common stock to charitable donor advised funds in February 2024. For both of the three months ended September 30, 2024 and 2023, the amount includes $0.2 million of employer payroll taxes associated with releases of RSUs and option exercises. For the nine months ended September 30, 2024 and 2023, the amount includes $0.7 million and $0.4 million, respectively, of employer payroll taxes associated with releases of RSUs and option exercises. |
|
| (2) | Represents charitable expense recorded in connection with the donation of 178,572 shares of Class A common stock in both May 2024 and August 2023 to the Warby Parker Impact Foundation and 56,938 shares of Class A common stock to charitable donor advised funds in June 2023. |
|
| (3) | Represents the amortization of costs capitalized in connection with the implementation of cloud-based software. |
|
| (4) | Represents internal and external non-capitalized costs related to the implementation of our new Enterprise Resource Planning (“ERP”) system. |
|
| (5) | Represents charges for certain legal matters outside the ordinary course of business. |
|
Warby Parker Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Measures (Unaudited)
The following table presents our non-GAAP, or adjusted, financial measures for the periods presented as a percentage of revenue. Each cost and operating expense is adjusted for stock-based compensation expense and related employer payroll taxes, non-cash charitable donations, charges for certain legal matters outside the ordinary course of business, and non-recurring costs such as restructuring costs, major system implementation costs, and transaction costs.
|
Reported |
|
Adjusted |
|
Reported |
|
Adjusted |
||||||||||||||||||||||||
|
Three Months Ended
|
|
Three Months Ended
|
|
Nine Months Ended
|
|
Nine Months Ended
|
||||||||||||||||||||||||
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
(unaudited, in thousands) |
|
(unaudited, in thousands) |
|
(unaudited, in thousands) |
|
(unaudited, in thousands) |
||||||||||||||||||||||||
Cost of goods sold |
$ |
87,580 |
|
|
$ |
77,117 |
|
|
$ |
87,299 |
|
|
$ |
76,835 |
|
|
$ |
256,964 |
|
|
$ |
229,752 |
|
|
$ |
256,154 |
|
|
$ |
228,976 |
|
% of Revenue |
|
45.5 |
% |
|
|
45.4 |
% |
|
|
45.4 |
% |
|
|
45.2 |
% |
|
|
44.3 |
% |
|
|
45.2 |
% |
|
|
44.1 |
% |
|
|
45.1 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Gross profit |
$ |
104,867 |
|
|
$ |
92,732 |
|
|
$ |
105,148 |
|
|
$ |
93,014 |
|
|
$ |
323,708 |
|
|
$ |
278,158 |
|
|
$ |
324,518 |
|
|
$ |
278,934 |
|
% of Revenue |
|
54.5 |
% |
|
|
54.6 |
% |
|
|
54.6 |
% |
|
|
54.8 |
% |
|
|
55.7 |
% |
|
|
54.8 |
% |
|
|
55.9 |
% |
|
|
54.9 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Selling, general, and administrative expenses |
$ |
111,480 |
|
|
$ |
112,499 |
|
|
$ |
100,624 |
|
|
$ |
93,353 |
|
|
$ |
344,404 |
|
|
$ |
328,585 |
|
|
$ |
302,166 |
|
|
$ |
267,261 |
|
% of Revenue |
|
57.9 |
% |
|
|
66.2 |
% |
|
|
52.3 |
% |
|
|
55.0 |
% |
|
|
59.3 |
% |
|
|
64.7 |
% |
|
|
52.0 |
% |
|
|
52.6 |
% |
Warby Parker Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Measures (Unaudited)
The following table reflects a reconciliation of each non-GAAP, or adjusted, financial measure to its most directly comparable financial measure prepared in accordance with GAAP:
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
(unaudited, in thousands) |
|
(unaudited, in thousands) |
||||||||||||
Cost of goods sold |
$ |
87,580 |
|
|
$ |
77,117 |
|
|
$ |
256,964 |
|
|
$ |
229,752 |
|
Adjusted to exclude the following: |
|
|
|
|
|
|
|
||||||||
Stock-based compensation expense(1) |
|
281 |
|
|
|
282 |
|
|
|
810 |
|
|
|
776 |
|
Adjusted Cost of Goods Sold |
$ |
87,299 |
|
|
$ |
76,835 |
|
|
$ |
256,154 |
|
|
$ |
228,976 |
|
|
|
|
|
|
|
|
|
||||||||
Gross profit |
$ |
104,867 |
|
|
$ |
92,732 |
|
|
$ |
323,708 |
|
|
$ |
278,158 |
|
Adjusted to exclude the following: |
|
|
|
|
|
|
|
||||||||
Stock-based compensation expense(1) |
|
281 |
|
|
|
282 |
|
|
|
810 |
|
|
|
776 |
|
Adjusted Gross Profit |
$ |
105,148 |
|
|
$ |
93,014 |
|
|
$ |
324,518 |
|
|
$ |
278,934 |
|
|
|
|
|
|
|
|
|
||||||||
Selling, general, and administrative expenses |
$ |
111,480 |
|
|
$ |
112,499 |
|
|
$ |
344,404 |
|
|
$ |
328,585 |
|
Adjusted to exclude the following: |
|
|
|
|
|
|
|
||||||||
Stock-based compensation expense(1) |
|
10,680 |
|
|
|
16,184 |
|
|
|
38,563 |
|
|
|
53,720 |
|
Non-cash charitable donation(2) |
|
— |
|
|
|
2,591 |
|
|
|
2,196 |
|
|
|
3,191 |
|
ERP implementation costs(3) |
|
— |
|
|
|
371 |
|
|
|
— |
|
|
|
4,413 |
|
Other costs(4) |
|
176 |
|
|
|
— |
|
|
|
1,479 |
|
|
|
— |
|
Adjusted Selling, General, and Administrative Expenses |
$ |
100,624 |
|
|
$ |
93,353 |
|
|
$ |
302,166 |
|
|
$ |
267,261 |
|
|
|
|
|
|
|
|
|
||||||||
Net cash provided by operating activities |
$ |
27,282 |
|
|
$ |
19,931 |
|
|
$ |
78,832 |
|
|
$ |
47,326 |
|
Purchases of property and equipment |
|
(14,223 |
) |
|
|
(15,488 |
) |
|
|
(46,311 |
) |
|
|
(40,098 |
) |
Free Cash Flow |
$ |
13,059 |
|
|
$ |
4,443 |
|
|
$ |
32,521 |
|
|
$ |
7,228 |
|
| (1) | Represents expenses related to the Company’s equity-based compensation programs and related employer payroll taxes, which may vary significantly from period to period depending upon various factors including the timing, number, and the valuation of awards granted, and vesting of awards including the satisfaction of performance conditions, as well as the issuance of 48,486 Class A common stock to charitable donor advised funds in February 2024. For both of the three months ended September 30, 2024 and 2023, the amount includes $0.2 million of employer payroll taxes associated with releases of RSUs and option exercises. For the nine months ended September 30, 2024 and 2023, the amount includes $0.7 million and $0.4 million, respectively, of employer payroll taxes associated with releases of RSUs and option exercises. |
|
| (2) | Represents charitable expense recorded in connection with the donation of 178,572 shares of Class A common stock in both May 2024 and August 2023 to the Warby Parker Impact Foundation and 56,938 shares of Class A common stock to charitable donor advised funds in June 2023. |
|
| (3) | Represents internal and external non-capitalized costs related to the implementation of our new ERP system. |
|
| (4) | Represents charges for certain legal matters outside the ordinary course of business. |